<DOC>
	<DOCNO>NCT02887495</DOCNO>
	<brief_summary>The Scleroderma bioreposiTOry Pathogenesis Study ( STOP Scleroderma ) help researcher use clinical data human biospecimens investigate scleroderma patient develop certain complication disease . Patients confirm scleroderma , raynauds positive autoantibody invite participate . This research may help u understand prevent treat scleroderma disease .</brief_summary>
	<brief_title>The Scleroderma Biorepository Pathogenesis Study ( STOP Scleroderma )</brief_title>
	<detailed_description />
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<criteria>Age &gt; 18 year Able give inform consent . Diagnosed scleroderma positive autoantibody &lt; 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>biorepository</keyword>
</DOC>